Tailoring no donors metallopharmaceuticals: Ruthenium nitrosyl ammines and aliphatic tetraazamacrocycles

Current Medicinal Chemistry

Volumn 17, Issue 31, 2010, Pages 3643-3657

  Tfouni, E ^a   Doro, F G ^a   Figueiredo, L E ^a   Pereira, J C M ^a   Metzker, G ^a   Franco, D W ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Biological applications; Nitric oxide carriers; Nitrosyls; Ruthenium

Indexed keywords

HETEROCYCLIC COMPOUND; MACROCYCLIC COMPOUND; NITRIC OXIDE; NITRIC OXIDE DONOR; NITROSO DERIVATIVE; RUTHENIUM DERIVATIVE; SCAVENGER;

ANTIPROTOZOAL ACTIVITY; ARTICLE; BIOAVAILABILITY; BLOOD PRESSURE REGULATION; DRUG BIOAVAILABILITY; DRUG CYTOTOXICITY; DRUG DISTRIBUTION; HIPPOCAMPUS; IN VIVO STUDY; LEISHMANIA MAJOR; MITOCHONDRION; NONHUMAN; OXIDATION REDUCTION POTENTIAL; OXIDATION REDUCTION REACTION; PHOTOCHEMISTRY; REDUCTION; TRYPANOSOMA CRUZI; TUMOR CELL;

AMINES; ANIMALS; LIGANDS; MALE; MICE; NITRIC OXIDE; NITRIC OXIDE DONORS; NITROUS OXIDE; ORGANOMETALLIC COMPOUNDS; OXIDATION-REDUCTION; PHOTOCHEMICAL PROCESSES; RATS; RUTHENIUM; RUTHENIUM COMPOUNDS;

EID: 78449254727     PISSN: 09298673     EISSN: None     Source Type: Journal    
DOI: 10.2174/092986710793213788     Document Type: Article

References (163)

1. Zhu, J. J.; Thomas, A. Perovskite-type mixed oxides as catalytic material for NO removal. Appl. Catal. B-Environ., 2009, 92, 225233.
2. Ignarro, L. J.; Buga, G. M.; Wood, K. S.; Byrns, R. E.; Chaudhuri, G. Endothelium-derived relaxing factor produced and released from artery and vein is nitric-oxide. Proc. Natl. Acad. Sci.USA, 1987, 84, 9265-9269.
3. Moncada, S.; Palmer, R. M. J.; Higgs, E. A. Nitric-oxide physiology, pathophysiology, and pharmacology. Pharmacol. Rev., 1991, 43, 109-142.
4. Palmer, R. M. J.; Ferrige, A. G.; Moncada, S. Nitric-oxide release accounts for the biological-activity of endothelium-derived relaxing factor. Nature, 1987, 327, 524-526.
5. Furchgott, R. F. Endothelium-derived relaxing factor: Discovery, early studies, and identifcation as nitric oxide (Nobel lecture). Angew. Chem. Int. Ed., 1999, 38, 1870-1880.
6. Waldman, S. A.; Murad, F. Cyclic-gmp synthesis and function. Pharmacol. Rev., 1987, 39, 163-196.
7. Arnold, W. P.; Mittal, C. K.; Katsuki, S.; Murad, F. Nitric-oxide activates guanylate cyclase and increases guanosine 3'-5'-cyclic monophosphate levels in various tissue preparations. Proc. Natl. Acad. Sci. USA, 1977, 74, 3203-3207.
8. Ignarro, L. J. Nitric Oxide; Biology and Pathobiology, Academic Press, USA, 2000,
9. Bian, K.; Doursout, M. F.; Murad, F. Vascular system: Role of nitric oxide in cardiovascular diseases. J. Clin. Hypertens., 2008, 10, 304-310.
10. Schulz, R.; Kelm, M.; Heusch, G. Nitric oxide in myocardial ischemia/reperfusion injury. Cardiovasc. Res., 2004, 61, 402-413.
11. Gkaliagkousi, E.; Douma, S.; Zamboulis, C.; Ferro, A. Nitric oxide dysfunction in vascular endothelium and platelets: role in essential hypertension. J. Hypertens., 2009, 27, 2310-2320.
12. Garthwaite, J. Concepts of neural nitric oxide-mediated transmission. Eur. J. Neurosci., 2008, 27, 2783-2802.
13. Bogdan, C. Nitric oxide and the immune response. Nat. Immunol., 2001, 2, 907-916.
14. MacMicking, J.; Xie, Q. W.; Nathan, C. Nitric oxide and macrophage function. Annu. Rev. Immunol., 1997, 15, 323-350.
15. Fang, F. C. Mechanisms of nitric oxide-related antimicrobial activity. J. Clin. Invest., 1997, 99, 2818-2825.
16. Wink, D. A.; Vodovotz, Y.; Cook, J. A.; Krishna, M. C.; Kim, S.; Coffin, D.; DeGraff, W.; Deluca, A. M.; Liebmann, J.; Mitchell, J. B. The role of nitric oxide chemistry in cancer treatment. Biochemistry-Moscow, 1998, 63, 802-809.
17. Contestabile, A. Targeting nitric oxide for tumor therapy. Curr. Pharm. Des., 2010, 16, 378-380.
18. Hickok, J. R.; Thomas, D. D. Nitric oxide and cancer therapy: the emperor has NO clothes. Curr. Pharm. Des., 2010, 16, 381-391.
19. Wink, D. A.; Vodovotz, Y.; Laval, J.; Laval, F.; Dewhirst, M. W.; Mitchell, J. B. The multifaceted roles of nitric oxide in cancer. Carcinogenesis, 1998, 19, 711-721.
20. Mocellin, S. Nitric Oxide: Cancer Target or Anticancer Agent? Curr. Cancer Drug Targets, 2009, 9, 214-236.
21. Gkaliagkousi, E.; Ritter, J.; Ferro, A. Platelet-derived nitric oxide signaling and regulation. Circ. Res., 2007, 101, 654-662.
22. Loscalzo, J. Nitric oxide insufficiency, platelet activation, and arterial thrombosis. Circ. Res., 2001, 88, 756-762.
23. Sen, C. K.; Roy, S. Redox signals in wound healing. Biochim. Biophys. Acta-General Subjects, 2008, 1780, 1348-1361.
24. Filippin, L. I.; Moreira, A. J.; Marroni, N. P.; Xavier, R. M. Nitric oxide and repair of skeletal muscle injury. Nitric Oxide, 2009, 21, 157-163.
25. Wink, D. A.; Mitchell, J. B. Chemical biology of nitric oxide: Insights into regulatory, cytotoxic, and cytoprotective mechanisms of nitric oxide. Free Radic. Biol. Med., 1998, 25, 434-456.
26. Thomas, D. D.; Ridnour, L. A.; Isenberg, J. S.; Flores-Santana, W.; Switzer, C. H.; Donzelli, S.; Hussain, P.; Vecoli, C.; Paolocci, N.; Ambs, S.; Colton, C. A.; Harris, C. C.; Roberts, D. D.; Wink, D. A. The chemical biology of nitric oxide: Implications in cellular sig-naling. Free Radic. Biol. Med., 2008, 45, 18-31.
27. Hall, C. N.; Garthwaite, J. What is the real physiological NO concentration in vivo? Nitric Oxide, 2009, 21, 92-103.
28. Wink, D. A.; Grisham, M. B.; Mitchell, J. B.; Ford, P. C. Direct and indirect effects of nitric oxide in chemical reactions relevant to biology. Nitric Oxide, Pt A Sources and Detection of No; No Synthase, 1996, 268, 12-31.
29. Miranda, K. M.; Espey, M. G.; Wink, D. A. A discussion of the chemistry of oxidative and nitrosative stress in cytotoxicity. J. Inorg. Biochem., 2000, 79, 237-240.
30. Ridnour, L. A.; Thomas, D. D.; Mancardi, D.; Espey, M. G.; Miranda, K. M.; Paolocci, N.; Feelisch, M.; Fukuto, J.; Wink, D. A. The chemistry of nitrosative stress induced by nitric oxide and reactive nitrogen oxide species. Putting perspective on stressful biological situations. Biol. Chem., 2004, 385, 1-10.
31. Lubos, E.; Handy, D. E.; Loscalzo, J. Role of oxidative stress and nitric oxide in atherothrombosis. Front. Biosci., 2008, 13, 5323-5344.
32. Burnett, A. L. Nitric oxide-based therapy for erectile disorders. Drug Discov. Today Ther. Strateg., 2005, 2, 25-30.
33. Wessel, D. L.; Adatia, I.; Giglia, T. M.; Thompson, J. E.; Kulik, T. J. Use of inhaled nitric-oxide and acetylcholine in the evaluation of pulmonary-hypertension and endothelial function after cardiopulmonary bypass. Circulation, 1993, 88, 2128-2138.
34. Yoo, J.; Fukuto, J. M. Oxidation of N-hydroxyguanidine by nitric oxide the possible generation of vasoactive species. Biochem. Pharmacol., 1995, 50, 1995-2000.
35. Mansuy, D.; Boucher, J. L. Alternative nitric oxide-producing substrates for no synthases. Free Radic. Biol. Med., 2004, 37, 1105-1121.
36. Thatcher, G. R. J.; Nicolescu, A. C.; Bennett, B. M.; Toader, V. Nitrates and no release: contemporary aspects in biological and medicinal chemistry. Free Radic. Biol. Med., 2004, 37, 1122-1143.
37. Al Sa'doni, H. H.; Ferro, A. Current status and future possibilities of nitric oxide-donor drugs: Focus on S-nitrosothiols. Mini Rev. Med. Chem., 2005, 5, 247-254.
38. Ford, P. C.; Bourassa, J.; Miranda, K.; Lee, B.; Lorkovic, I.; Boggs, S.; Kudo, S.; Laverman, L. Photochemistry of metal nitrosyl complexes. Delivery of nitric oxide to biological targets. Coord. Chem. Rev., 1998, 171, 185-202.
39. Reglinski, J.; Butler, A. R.; Glidewell, C. Metal nitrosyl complexes as a source of new vasodilators strategies derived from systematic chemistry and nitrosyl ligand reactivity. Appl. Organomet. Chem., 1994, 8, 25-31.
40. Wang, P. G.; Xian, M.; Tang, X. P.; Wu, X. J.; Wen, Z.; Cai, T. W.; Janczuk, A. J. Nitric oxide donors: Chemical activities and biological applications. Chem. Rev., 2002, 102, 1091-1134.
41. Rose, M. J.; Mascharak, P. K. Fiat Lux: selective delivery of high flux of nitric oxide (NO) to biological targets using photoactive metal nitrosyls. Curr. Op. Chem. Biol., 2008, 12, 238-244.
42. Gao, Q.; Wan, A. J. NO releasing diazeniumdiolates and targeting NO releasing materials. Prog. Chem., 2006, 18, 1101-1109.
43. Keefer, L. K. Nitric oxide (NO)and nitroxyl (HNO)-generating diazeniumdiolates (NONOates): Emerging commercial opportunities. Curr. Top. Med. Chem., 2005, 5, 625-634.
44. Davies, K. M.; Wink, D. A.; Saavedra, J. E.; Keefer, L. K. Chemistry of the diazeniumdiolates. 2. Kinetics and mechanism of dissociation to nitric oxide in aqueous solution. J. Am. Chem. Soc., 2001, 123, 5473-5481.
45. (0,1-) system: structure, chemical reactivity and biological assays. J. Inorg. Biochem., 2004, 98, 1921-1932.
46. 2+(1,4,8,11-tetraazacyclotetradecane). Inorg. Chem., 2000, 39, 2294-2300.
47. Gomes, M. G.; Davanzo, C. U.; Silva, S. C.; Lopes, L. G. F.; Santos, P. S.; Franco, D. W. cisand trans-nitrosyltetraammineruthenium(II). Spectral and electrochemical properties and reactivity. J. Chem. Soc. Dalton Trans., 1998, 601-607.
48. Marcondes, F. G.; Ferro, A. A.; Souza-Torsoni, A.; Sumitani, M.; Clarke, M. J.; Franco, D. W.; Tfouni, E.; Krieger, M. H. In vivo effects of the controlled NO donor/scavenger ruthenium cyclam complexes on blood pressure. Life Sci., 2002, 70, 2735-2752.
49. Toledo, J. C.; Silva, H. A. S.; Scarpellini, M.; Mori, V.; Camargo, A. J.; Bertotti, M.; Franco, D. W. Ruthenium tetraammines as a model of nitric oxide donor compounds. Eur. J. Inorg. Chem., 2004, 1879-1885.
50. Tfouni, E.; Ferreira, K. Q.; Doro, F. G.; da Silva, R. S.; da Rocha, Z. N. Ru(II) and Ru(III) complexes with cyclam and related species. Coord. Chem. Rev., 2005, 249, 405-418.
51. Tfouni, E.; Krieger, M.; McGarvey, B. R.; Franco, D. W. Structure, chemical and photochemical reactivity and biological activity of some ruthenium amine nitrosyl complexes. Coord. Chem. Rev., 2003, 236, 57-69.
52. Rose, M. J.; Mascharak, P. K. Photoactive ruthenium nitrosyls: Effects of light and potential application as NO donors. Coord. Chem. Rev., 2008, 252, 2093-2114.
53. 6- = triethylenetetraminehexaacetate). J. Inorg. Biochem., 1997, 68, 183-193.
54. Marmion, C. J.; Cameron, B.; Mulcahy, C.; Fricker, S. P. Ruthenium as an effective nitric oxide scavenger. Curr. Top. Med. Chem., 2004, 4, 1585-1603.
55. Ford, P. C.; Rudd, D. F. P.; Gaunder, R.; Taube, H. Synthesis and properties of pentaamminepyridineruthenium(II) and related pentaamminerulthenium complexes of aromatic nitrogen heterocycles. J. Am. Chem. Soc., 1968, 90, 1187
56. Ford, P. C. Properties and reactions of ruthenium(II) amine complexes. Coord. Chem. Rev., 1970, 5, 75
57. Au, Y. K.; Wong, W. T. Ruthenium 1994. Coord. Chem. Rev., 1997, 162, 417-475.
58. Taube, H. Substitution reaction of ruthenium ammines. Comm. Inorg. Chem., 1981, 1, 17-31.
59. Toledo, J. C.; Neto, B. D. S. L.; Franco, D. W. Mutual effects in the chemical properties of the ruthenium metal center and ancillary ligands upon coordination. Coord. Chem. Rev., 2005, 249, 419-431.
60. Creutz, C. Mixed-Valence Complexes of D5-D6 Metal Centers. Prog. Inorg. Chem., 1983, 30, 1-73.
61. Taube, H. Electron-transfer between metal-complexes a retrospective view (nobel lecture). Angew. Chem. Int. Ed., 1984, 23, 329-339.
62. Richter-Addo, G. B.; Legzdins, P. Metal Nitrosyls, Oxford University Press, 1992,
63. Enemark, J. H.; Feltham, R. D. Principles of structure, bonding, and reactivity for metal nitrosyl complexes. Coord. Chem. Rev., 1974, 13, 339-406.
64. (3+/2+) complexes. Inorg. Chim. Acta, 2000, 300, 698-708.
65. Caramori, G. F.; Frenking, G. The nature of the Ru-NO bond in ruthenium tetraammine nitrosyl complexes. Organometallics, 2007, 26, 5815-5825.
66. Oliveira, F. S.; Togniolo, V.; Pupo, T.; Tedesco, A. C.; da Silva, R. S. Nitrosyl ruthenium complex as nitric oxide delivery agent: synthesis, characterization and photochemical properties. Inorg. Chem. Commun., 2004, 7, 160-164.
67. Borges, S. D. S.; Davanzo, C. U.; Castellano, E. E.; Schpector, J.; Silva, S. C.; Franco, D. W. Ruthenium nitrosyl complexes with Nheterocyclic ligands. Inorg. Chem., 1998, 37, 2670-2677.
68. 3+ complex and its vasodilator activity based on visible light irradiation. Inorg. Chim. Acta, 2006, 359, 2543-2549.
69. Sauaia, M. G.; da Silva, R. S. The reactivity of nitrosyl ruthenium complexes containing polypyridyl ligands. Transit. Metal Chem., 2003, 28, 254-259.
70. Calandreli, I.; Oliveira, F. D.; Liang, G. G.; da Rocha, Z. N.; Tfouni, E. Synthesis and characterization of trans-[Ru(NO) Cl(L)4](PF6)2 (L = isonicotinamide; 4-acetylpyridine) and related species. Inorg. Chem. Commun., 2009, 12, 591-595.
71. Cavarzan, D. A.; Caetano, F. R.; Romualdo, L. L.; do Nascimento, F. B.; Batista, A. A.; Ellena, J.; Barison, A.; de Araujo, M. P. The first P-N containing RuCl3NO complex: fac-[RuCl3(NO)(P-N)] (P-N = [o-(N,N-dimethylamino)phenyl]diphenylphosphine). Inorg. Chem. Commun., 2006, 9, 1247-1250.
72. Von Poelhsitz, G.; Bogado, A. L.; de Araujo, M. P.; Selistre-DeAraujo, H. S.; Ellena, J.; Castellano, E. E.; Batista, A. A. Synthesis, characterization, X-ray structure and preliminary in vitro antitumor activity of the nitrosyl complex fac-[RuCl3(NO)(dppf)], dppf=1,1 'bis(diphenylphosphine)ferrocene. Polyhedron, 2007, 26, 47074712.
73. Von Poelhsitz, G.; Bogado, A. L.; de Souza, G. D.; Rodrigues, E.; Batista, A. A.; de Araujo, M. P. New nitrosyl ruthenium complex [RuCl(NO)(dcype)(bipy)](PF6)2: Synthesis, electrochemistry, NMR and ESI-MS/MS studies. Inorg. Chem. Commun., 2007, 10, 133138.
74. Bordini, J.; Novaes, D. O.; Borissevitch, I. E.; Owens, B. T.; Ford, P. C.; Tfouni, E. Acidity and photolability of ruthenium salen nitrosyl and aquo complexes in aqueous solutions. Inorg. Chim. Acta, 2008, 361, 2252-2258.
75. Hoshino, M.; Laverman, L.; Ford, P. C. Nitric oxide complexes of metalloporphyrins: an overview of some mechanistic studies. Coord. Chem. Rev., 1999, 187, 75-102.
76. Miranda, K. M.; Ford, P. C. Synthesis and characterization of metal porphyrin nitrosyl complexes with possible applications in photodynamic therapy. Abstr. Pap. Am. Chem. Soc., 1994, 207, 313-INOR.
77. Lorkovic, I. M.; Lee, B. E.; Miranda, K. M.; Ford, P. C. Nitric oxide disproportionation by Ru(porphyrin) and photochemistry of Ru(porphyrin)(NO)(X): A common intermediate? Abstracts of Papers of the American Chemical Society, 1999, 217, U960-U960.
78. de Barros, B. F.; Toledo, J. C.; Franco, D. W.; Tfouni, E.; Krieger, M. H. A new inorganic vasodilator, trans-[Ru(NO)(NH3)(4) (POEt)(3)](PF6)(3): hypotensive effect of endothelium-dependent and -independent vasodilators in different hypertensive animals models. Nitric Oxide, 2002, 7, 50-56.
79. 3+ complexes. Inorg. Chim. Acta, 2004, 357, 1381-1388.
80. Gomes, A. J.; Barbougli, P. A.; Espreafico, E. M.; Tfouni, E. trans[Ru(NO)(NH3)4(py)](BF4)3·H2O encapsulated in PLGA microparticles for delivery of nitric oxide to B16-F10 cells: Cytotoxicity and phototoxicity. J. Inorg. Biochem., 2008, 102, 757-766.
81. Pestana, C. R.; Phelippin, D. P. S.; Polizello, A. C. M.; Dorta, D. J.; Uyemura, S. A.; Santos, A. C.; Doro, F. G.; Rodrigues, F. P.; Tfouni, E.; Curti, C. Effects on mitochondria of mitochondriainduced nitric oxide release from a ruthenium nitrosyl complex. Nitric Oxide, 2009, 20, 24-30.
82. Torsoni, A. S.; de Barros, B. F.; Toledo, J. C.; Haun, M.; Krieger, M. H.; Tfouni, E.; Franco, D. W. Hypotensive properties and acute toxicity of trans-[Ru(NH3)4P(OEt)3(NO)](PF6)3, a new nitric oxide donor. Nitric Oxide, 2002, 6, 247-254.
83. Benini, P. G. Z.; Silva, J. J. N.; Franco, D. W. The vascular behavior of the [Ru(edta)(NO)] complex immobilized on PAMAM dendrimer. Nitric Oxide, 2006, 14, A54-A54.
84. 2+. Polyhedron, 2007, 26, 4746-4750.
85. Roncaroli, F.; Ruggiero, M. E.; Franco, D. W.; Estiu, G. L.; Olabe, J. A. Kinetic, mechanistic, and DFT study of the electrophilic reactions of nitrosyl complexes with hydroxide. Inorg. Chem., 2002, 41, 5760-5769.
86. Silva, J. J. J.; Osakabe, A. L.; Pavanelli, W. R.; Silva, J. S.; Franco, D. W. In vitro and in vivo antiproliferative and trypanocidal activities of ruthenium NO donors. Br. J. Pharmacol., 2007, 152, 112-121.
87. Silva, J. J. N.; Pavanelli, W. R.; Pereira, J. C. M.; Silva, J. S.; Franco, D. W. Experimental chemotherapy against Trypanosoma cruzi infection using ruthenium nitric oxide donors. Antimicrob. Agents Chemother., 2009, 53, 4414-4421.
88. Silva, J. J. N.; Pavanelli, W. R.; Gutierrez, F. R. S.; Lima, F. C. A.; da Silva, A. B. F.; Silva, J. S.; Franco, D. W. Complexation of the anti-Trypanosoma cruzi drug benznidazole improves solubility and efficacy. J. Med. Chem., 2008, 51, 4104-4114.
89. Silva, J. J. N.; Guedes, P. M. M.; Zotis, A.; Balliano, T. L.; Silva, F. O. N.; Lopes, L. G. F.; Ellena, J.; Oliva, G.; Andricopoulo, A. D.; Franco, D. W.; Silva, J. S. Novel ruthenium complexes as potential drugs for Chagas's disease: enzyme inhibition and in vitro/in vivo trypanocidal activity. Br. J. Pharmacol., 2010, 160, 260-269.
90. Silva, W. C.; Castellano, E. E.; Franco, D. W. Structural and reactivity changes in ruthenium ammines induced by the NO ligand. Polyhedron, 2004, 23, 1063-1067.
91. Zanichelli, P. G.; Estrela, H. F. G.; Spadari-Bratfisch, R. C.; Grassi-Kassisse, D. M.; Franco, D. W. The effects of ruthenium tetraammine compounds on vascular smooth muscle. Nitric Oxide, 2007, 16, 189-196.
92. Wieraszko, A.; Clarke, M. J.; Lang, D. R.; Lopes, L. G. F.; Franco, D. W. The influence of NO-containing ruthenium complexes on mouse hippocampal evoked potentials in vitro. Life Sci., 2001, 68, 1535-1544.
93. . Br. J. Pharmacol. doi:110.1111/j.14765381.2009.00576.x, 2010,
94. Bertotti, M.; Mori, V.; Zanichelli, P.; Toledo, J. C.; Franco, D. W. Electrochemical and spectrophotometric methods for evaluation of NO dissociation rate constants from nitrosyl metal complexes activated through reduction. Nitric Oxide, 2005, 396, 45-53.
95. Bezerra, C. W. B.; da Silva, S. C.; Gambardella, M. T. P.; Santos, R. H. A.; Plicas, L. M. A.; Tfouni, E.; Franco, D. W. Water pidonation in trans-tetraammineruthenium(II): Effect on coordinatedwater properties induced by a trans NO ligand. Inorg. Chem., 1999, 38, 5660-5667.
96. 2+. Spectrochim. Acta A, 1999, 55, 1515-1525.
97. LimaNeto, B. S.; Nascimento, J. C.; Franco, D. W. Trans effect and trans influence in ruthenium(II) tetraammines: Imidazole as a probe ligand. Polyhedron, 1996, 15, 1965-1970.
98. 2+ (P(III)=P(OR)3,P(R)3). Inorg. Chim. Acta, 1997, 254, 79-83.
99. McGarvey, B. R.; Ferro, A. A.; Tfouni, E.; Bezerra, C. W. B.; Bagatin, I.; Franco, D. W. Detection of the EPR spectra of NO center dot in ruthenium(II) complexes. Inorg. Chem., 2000, 39, 35773581.
100. 3 ligand denticity change upon mono-Nsubstitution with a carboxypropyl pendant arm in a ruthenium nitrosyl complex. Inorg. Chem., 2008, 47, 4118-4125.
101. 2+. Oxidation of the coordinated 1,4,7,10tetraazacyclododecane (cyclen) ligand. Inorg. Chem. Commun., 2004, 7, 204-208.
102. -, H2O). Inorg. Chim. Acta, 2003, 355, 205-212.
103. Sauaia, M. G.; Oliveira, F. D. S.; de Lima, R. G.; Cacciari, A. D. L.; Tfouni, E.; da Silva, R. S. Syntheses, characterization and photochemical properties of new NO center dot-ruthenium(II) complexes. Inorg. Chem. Commun., 2005, 8, 347-349.
104. 2+. J. Inorg. Biochem., 2007, 101, 313-320.
105. da Rocha, Z. N.; de Lima, R. G.; Doro, F. G.; Tfouni, E.; da Silva, R. S. Photochemical production of nitric oxide from a nitrosyl phthalocyanine ruthenium complex by irradiation with light in the phototherapeutic window. Inorg. Chem. Commun., 2008, 11, 737740.
106. Jones, D. P.; Go, Y. M.; Anderson, C. L.; Ziegler, T. R.; Kinkade, J. M.; Kirlin, W. G. Cysteine/cystine couple is a newly recognized node in the circuitry for biologic redox signaling and control. FASEB J., 2004, 18, 1246-1252.
107. Oprian, D. D.; Coon, M. J. Oxidation-Reduction States of FMN and FAD in NADPH-Cytochrome-P-450 Reductase During Reduction by Nadph. J. Biol. Chem., 1982, 257, 8935-8944.
108. Millis, K. K.; Weaver, K. H.; Rabenstein, D. L. Oxidationreduction potential of glutathione. J. Org. Chem., 1993, 58, 41444146.
109. Salvati, L.; Mattu, M.; Colasanti, M.; Scalone, A.; Venturini, G.; Gradoni, L.; Ascenzi, P. NO donors inhibit Leishmania infantum cysteine proteinase activity. Biochim. Biophys. Acta-Protein Struct. Mol. Enzymol., 2001, 1545, 357-366.
110. Masters, B. R.; So, P. T. C.; Gratton, E. Multiphoton excitation fluorescence microscopy and spectroscopy of in vivo human skin. Biophys. J., 1997, 72, 2405-2412.
111. Diwu, Z. J.; Lown, J. W. Phototherapeutic potential of alternative photosensitizers to porphyrins. Pharmacol. Ther., 1994, 63, 1-35.
112. Rose, M. J.; Fry, N. L.; Marlow, R.; Hinck, L.; Mascharak, P. K. Sensitization of ruthenium nitrosyls to visible light via direct coordination of the dye resorufin: Trackable NO donors for lighttriggered NO delivery to cellular targets. J. Am. Chem. Soc., 2008, 130, 8834-8846.
113. Wecksler, S. R.; Mikhailovsky, A.; Korystov, D.; Ford, P. C. A two-photon antenna for photochemical delivery of nitric oxide from a water-soluble, dye-derivatized iron nitrosyl complex using NIR light. J. Am. Chem. Soc., 2006, 128, 3831-3837.
114. Mowbray, M.; Weller, R. The effects of ultraviolet radiation on nitric oxide stores in human skin. Br. J. Dermatol., 2006, 155, 245245.
115. Iskander, D.; Weller, R. Nitric oxide suppression of apoptosis in human skin following UV irradiation. Br. J. Dermatol., 2005, 152, 847-847.
116. Weller, R. Nitric oxide: a key mediator in cutaneous physiology. Clin. Exp. Dermatol., 2003, 28, 511-514.
117. Garthwaite, J.; Boulton, C. L. Nitric-oxide signaling in the centralnervous-system. Ann. Rev. Physiol., 1995, 57, 683-706.
118. McCleverty, J. A. Chemistry of nitric oxide relevant to biology. Chem. Rev., 2004, 104, 403-418.
119. Brown, G. C. Nitric oxide and mitochondrial respiration. Biochim. Biophys. Acta-Bioenerg., 1999, 1411, 351-369.
120. Henry, Y.; Guissani, A. Interactions of nitric oxide with hemoproteins: roles of nitric oxide in mitochondria. Cell Mol. Life Sci., 1999, 55, 1003-1014.
121. Toledo, J. C.; Lopes, L. G. D.; Alves, A. A.; da Silva, L. P.; Franco, D. W. Release of NO by a nitrosyl complex upon activation by the mitochondrial reducing power. J. Inorg. Biochem., 2002, 89, 267-271.
122. Moore, C. L. Specific inhibition of mitochondrial Ca++ transport by ruthenium red. Biochem. Biophys. Res. Commun., 1971, 42, 298.
123. Ying, W. L.; Emerson, J.; Clarke, M. J.; Sanadi, D. R. Inhibition of mitochondrial calcium-ion transport by an oxo-bridged dinuclear ruthenium ammine complex. Biochemistry, 1991, 30, 4949-4952.
124. Trollinger, D. R.; Cascio, W. E.; Lemasters, J. J. Mitochondrial calcium transients in adult rabbit cardiac myocytes: Inhibition by ruthenium red and artifacts caused by lysosomal loading of Ca2+indicating fluorophores. Biophys. J., 2000, 79, 39-50.
125. Metzker, G.; Cardoso, D. R.; Franco, D. W. Manuscript in preparation.
126. Singh, R. J.; Hogg, N.; Joseph, J.; Kalyanaraman, B. Mechanism of nitric oxide release from S-nitrosothiols. J. Biol. Chem., 1996, 271, 18596-18603.
127. Friederich, J. A.; Butterworth, J. F. Sodium-nitroprusside 20 years and counting. Anesth. Analg., 1995, 81, 152-162.
128. 3-. Inorg. Chem., 2003, 42, 4179-4189.
129. Benini, P. G. Z.; McGarvey, B. R.; Franco, D. W. Functionalization of PAMAM dendrimers with [Ru-III(edta)(H2O)](-)1. Nitric Oxide, 2008, 19, 245-251.
130. Bonaventura, D.; de Lima, R. G.; Vercesi, J. A.; da Silva, R. S.; Bendhack, L. M. Comparison of the mechanisms underlying the relaxation induced by two nitric oxide donors: Sodium nitroprusside and a new ruthenium complex. Vasc. Pharmacol., 2007, 46, 215222.
131. de Gaitani, C. M.; de Melo, M. C. C.; Lunardi, C. N.; Oliveira, F. D.; da Silva, R. S.; Bendhack, L. M. Hypotensive effect of the nitrosyl ruthenium complex nitric oxide donor in renal hypertensive rats. Nitric Oxide, 2009, 20, 195-199.
132. de Lima, R. G.; Sauaia, M. G.; Bonaventura, D.; Tedesco, A. C.; Lopez, R. F. V.; Bendhack, L. M.; da Silva, R. S. Controlled nitric oxide photo-release from nitro ruthenium complexes: The vasodilator response produced by UV light irradiation. Inorg. Chim. Acta, 2005, 358, 2643-2650.
133. Madhani, M.; Patra, A. K.; Miller, T. W.; Eroy-Reveles, A. A.; Hobbs, A. J.; Fukuto, J. M.; Mascharak, P. K. Biological activity of designed photolabile metal nitrosyls: Light-dependent activation of soluble guanylate cyclase and vasorelaxant properties in rat aorta. J. Med. Chem., 2006, 49, 7325-7330.
134. ·-. J. Biol. Chem., 2003, 278, 50949-50955.
135. +] ion on the surface of functionalized silica gel. Langmuir, 2006, 22, 203-208.
136. Doro, F. G.; Rodrigues, U. P.; Tfouni, E. A regenerable ruthenium tetraammine nitrosyl complex immobilized on a modified silica gel surface: Preparation and studies of nitric oxide release and nitriteto-NO conversion. J. Coll. Interf. Sci., 2007, 307, 405-417.
137. MacCarthur, P.H.; Shiva, S.; Gladwin, M.T.; Measurement of circulating nitrite and S-nitrosothiols by reductive chemiluminescence. J. Chromatography B, 2007, 851, 93-105.
138. Ocakoglu, K.; Yildrim, Y.; Lambrecht, F. Y.; Ocal, J.; Icli, S. Biological investigation of I-131-labeled new water soluble Ru(II) polypyridyl complex. Appl. Radiat. Isot., 2008, 66, 115-121.
139. Rodrigues, J. A.; Torsoni, A. S.; Franco, D. W.; Haun, M. XXVIa Reunião Anual da Sociedade Brasileira de Bioquimica e Biologia Molecular-SBBq, Caxambu, 3rd-6th, May, 1997, S32.
140. Schlede, E.; Genschow, E.; Spielmann, H.; Stropp, G.; Kayser, D. Oral acute toxic class method: A successful alternative to the oral LD50 test. Regul. Toxicol. Pharmacol., 2005, 42, 15-23.
141. Pereira, J. C. M.; Carregaro, V.; Costa, D. L.; Silva, J. S.; Cunha, F.; Franco, D. W. Antileishmanial activity of ruthenium(II)tetraamine nitrosyl complex. Eur. J. Med. Chem. doi: 10.1016/j.ejmech.2010.06.010.
142. Otero, L.; Noblia, P.; Gambino, D.; Cerecetto, H.; Gonzalez, M.; Ellena, J. A.; Piro, O. E. Synthesis and characterization of new ruthenium complexes with active ligands against Chagas' disease. Inorg. Chim. Acta, 2003, 344, 85-94.
143. Pagano, M.; Demoro, B.; Toloza, J.; Boiani, L.; Gonzalez, M.; Cerecetto, H.; Olea-Azar, C.; Norambuena, E.; Gambino, D.; Otero, L. Effect of ruthenium complexation on trypanocidal activity of 5-nitrofuryl containing thiosemicarbazones. Eur. J. Med. Chem., 2009, 44, 4937-4943.
144. Abrahamsohn, I. A.; Coffman, R. L. Cytokine and nitric-oxide regulation of the immunosuppression in Trypanosoma Cruzi infection. J. Immunol., 1995, 155, 3955-3963.
145. Martinez-Diaz, R. A.; Escario, J. A.; Nogal-Ruiz, J. J.; GomezBarrio, A. Biological characterization of Trypanosoma cruzi strains. Memorias do Instituto Oswaldo Cruz, 2001, 96, 53-59.
146. Martins, G. A.; Cardoso, M. A. G.; Aliberti, J. C. S.; Silva, J. S. Nitric oxide-induced apoptotic cell death in the acute phase of Trypanosoma cruzi infection in mice. Immun. Lett., 1998, 63, 113-120.
147. Huang, H.; Chan, J.; Wittner, M.; Jelicks, L. A.; Morris, S. A.; Factor, S. M.; Weiss, L. M.; Braunstein, V. L.; Bacchi, C. J.; Yarlett, N.; Chandra, M.; Shirani, J.; Tanowitz, H. B. Expression of cardiac cytokines and inducible form of nitric oxide synthase (NOS2) in Trypanosoma cruzi-infected mice. J. Mol. Cell. Cardiol., 1999, 31, 75-88.
148. Guido, R. V. C.; Oliva, G.; Montanari, C. A.; Andricopulo, A. D. Structural basis for selective inhibition of trypanosomatid glyceraldehyde-3-phosphate dehydrogenase: Molecular docking and 3D QSAR studies. J. Chem. Inform. Model., 2008, 48, 918-929.
149. Frost, M. C.; Reynolds, M. M.; Meyerhoff, M. E. Polymers incorporating nitric oxide releasing/generating substances for improved biocompatibility of blood-contactincy medical devices. Biomaterials, 2005, 26, 1685-1693.
150. Riccio, D. A.; Dobmeier, K. P.; Hetrick, E. M.; Privett, B. J.; Paul, H. S.; Schoenfisch, M. H. Nitric oxide-releasing S-nitrosothiolmodified xerogels. Biomaterials, 2009, 30, 4494-4502.
151. Marxer, S. M.; Rothrock, A. R.; Nablo, B. J.; Robbins, M. E.; Schoenfisch, M. H. Preparation of nitric oxide (NO)-releasing solgels for biomaterial applications. Chem. Mat., 2003, 15, 41934199.
152. Eroy-Reveles, A. A.; Mascharak, P. K. Nitric oxide-donating materials and their potential in pharmacological applications for sitespecific nitric oxide delivery. Fut. Med. Chem., 2009, 1, 1497-1507.
153. Hwang, S.; Meyerhoff, M. E. Polyurethane with tethered copper(II)-cyclen complex: Preparation, characterization and catalytic generation of nitric oxide from S-nitrosothiols. Biomaterials, 2008, 29, 2443-2452.
154. Oh, B. K.; Meyerhoff, M. E. Catalytic generation of nitric oxide from nitrite at the interface of polymeric films doped with lipophilic Cu(Il)-complex: a potential route to the preparation of thromboresistant coatings. Biomaterials, 2004, 25, 283-293.
155. Hetrick, E. M.; Schoenfisch, M. H. Reducing implant-related infections: active release strategies. Chem. Soc. Rev., 2006, 35, 780-789.
156. Chang, C. I.; Liao, J. C.; Kuo, L. Arginase modulates nitric oxide production in activated macrophages. Am. J. Physiol. Heart Circ. Physiol., 1998, 43, H342-H348.
157. Tfouni, E.; Doro, F. G.; Gomes, A. J.; da Silva, R. S.; Metzker, G.; Benini, P. G. Z.; Franco, D. W. Immobilized ruthenium complexes and aspects of their reactivity. Coord. Chem. Rev., 2010, 254, 355371.
158. Ferreira, K. Q.; Schneider, J. F.; Nascente, P. A. P.; Rodrigues, U. P.; Tfouni, E. Design of an NO photoinduced releaser xerogel based on the controlled nitric oxide donor trans trans[Ru(NO)Cl(cyclam)](PF6)2 (cyclam=1,4,8, 11-tetraazacyclotetradecane). J. Coll. Interf. Sci., 2006, 300, 543-552.
159. Bordini, J.; Ford, P. C.; Tfouni, E. Photochemical release of nitric oxide from a regenerable, sol-gel encapsulated Ru-salen-nitrosyl complex. Chem. Commun., 2005, 4169-4171.
160. Iller, R. K. The Chemistry of Silica, Wiley, New York, 1979.
161. Monttola, H. A.; Steimetz, J. R. Chemically Modified Surfaces, Elsevier, New York, 1992.
162. Mundargi, R. C.; Babu, V. R.; Rangaswamy, V.; Patel, P.; Aminabhavi, T. M. Nano/micro technologies for delivering macromolecular therapeutics using poly(D,L-lactide-co-glycolide) and its derivatives. J. Control. Release, 2008, 125, 193-209.
163. Kim, Y. M.; Bombeck, C. A.; Billiar, T. R. Nitric oxide as a bifunctional regulator of apoptosis. Circ. Res., 1999, 84, 253-256.